Paediatric cancer stage in population-based cancer registries: the Toronto consensus principles and guidelines

Sumit Gupta, Joanne F. Aitken, Ute Bartels, James Brierley, Mae Dolendo, Paola Friedrich, Soad Fuentes-Alabi, Claudia P. Garrido, Gemma Gatta, Mary Gospodarowicz, Thomas Gross, Scott C. Howard, Elizabeth Molyneux, Florencia Moreno, Jason D. Pole, Kathy Pritchard-Jones, Oscar Ramirez, Lynn A.G. Ries, Carlos Rodriguez-Galindo, Hee Young ShinEva Steliarova-Foucher, Lillian Sung, Eddy Supriyadi, Rajaraman Swaminathan, Julie Torode, Tushar Vora, Tezer Kutluk, A. Lindsay Frazier

Research output: Contribution to journalReview article

15 Citations (Scopus)

Abstract

Population-based cancer registries generate estimates of incidence and survival that are essential for cancer surveillance, research, and control strategies. Although data on cancer stage allow meaningful assessments of changes in cancer incidence and outcomes, stage is not recorded by most population-based cancer registries. The main method of staging adult cancers is the TNM classification. The criteria for staging paediatric cancers, however, vary by diagnosis, have evolved over time, and sometimes vary by cooperative trial group. Consistency in the collection of staging data has therefore been challenging for population-based cancer registries. We assembled key experts and stakeholders (oncologists, cancer registrars, epidemiologists) and used a modified Delphi approach to establish principles for paediatric cancer stage collection. In this Review, we make recommendations on which staging systems should be adopted by population-based cancer registries for the major childhood cancers, including adaptations for low-income countries. Wide adoption of these guidelines in registries will ease international comparative incidence and outcome studies.

Original languageEnglish (US)
Pages (from-to)e163-e172
JournalThe Lancet Oncology
Volume17
Issue number4
DOIs
StatePublished - Apr 1 2016

Fingerprint

Registries
Guidelines
Pediatrics
Population
Neoplasms
Neoplasm Staging
Incidence
Cohort Studies
Outcome Assessment (Health Care)
Research

All Science Journal Classification (ASJC) codes

  • Oncology

Cite this

Gupta, S., Aitken, J. F., Bartels, U., Brierley, J., Dolendo, M., Friedrich, P., ... Frazier, A. L. (2016). Paediatric cancer stage in population-based cancer registries: the Toronto consensus principles and guidelines. The Lancet Oncology, 17(4), e163-e172. https://doi.org/10.1016/S1470-2045(15)00539-2

Paediatric cancer stage in population-based cancer registries : the Toronto consensus principles and guidelines. / Gupta, Sumit; Aitken, Joanne F.; Bartels, Ute; Brierley, James; Dolendo, Mae; Friedrich, Paola; Fuentes-Alabi, Soad; Garrido, Claudia P.; Gatta, Gemma; Gospodarowicz, Mary; Gross, Thomas; Howard, Scott C.; Molyneux, Elizabeth; Moreno, Florencia; Pole, Jason D.; Pritchard-Jones, Kathy; Ramirez, Oscar; Ries, Lynn A.G.; Rodriguez-Galindo, Carlos; Shin, Hee Young; Steliarova-Foucher, Eva; Sung, Lillian; Supriyadi, Eddy; Swaminathan, Rajaraman; Torode, Julie; Vora, Tushar; Kutluk, Tezer; Frazier, A. Lindsay.

In: The Lancet Oncology, Vol. 17, No. 4, 01.04.2016, p. e163-e172.

Research output: Contribution to journalReview article

Gupta, S, Aitken, JF, Bartels, U, Brierley, J, Dolendo, M, Friedrich, P, Fuentes-Alabi, S, Garrido, CP, Gatta, G, Gospodarowicz, M, Gross, T, Howard, SC, Molyneux, E, Moreno, F, Pole, JD, Pritchard-Jones, K, Ramirez, O, Ries, LAG, Rodriguez-Galindo, C, Shin, HY, Steliarova-Foucher, E, Sung, L, Supriyadi, E, Swaminathan, R, Torode, J, Vora, T, Kutluk, T & Frazier, AL 2016, 'Paediatric cancer stage in population-based cancer registries: the Toronto consensus principles and guidelines', The Lancet Oncology, vol. 17, no. 4, pp. e163-e172. https://doi.org/10.1016/S1470-2045(15)00539-2
Gupta, Sumit ; Aitken, Joanne F. ; Bartels, Ute ; Brierley, James ; Dolendo, Mae ; Friedrich, Paola ; Fuentes-Alabi, Soad ; Garrido, Claudia P. ; Gatta, Gemma ; Gospodarowicz, Mary ; Gross, Thomas ; Howard, Scott C. ; Molyneux, Elizabeth ; Moreno, Florencia ; Pole, Jason D. ; Pritchard-Jones, Kathy ; Ramirez, Oscar ; Ries, Lynn A.G. ; Rodriguez-Galindo, Carlos ; Shin, Hee Young ; Steliarova-Foucher, Eva ; Sung, Lillian ; Supriyadi, Eddy ; Swaminathan, Rajaraman ; Torode, Julie ; Vora, Tushar ; Kutluk, Tezer ; Frazier, A. Lindsay. / Paediatric cancer stage in population-based cancer registries : the Toronto consensus principles and guidelines. In: The Lancet Oncology. 2016 ; Vol. 17, No. 4. pp. e163-e172.
@article{a09cc72fb6d04426ba2ba46235dbb8bc,
title = "Paediatric cancer stage in population-based cancer registries: the Toronto consensus principles and guidelines",
abstract = "Population-based cancer registries generate estimates of incidence and survival that are essential for cancer surveillance, research, and control strategies. Although data on cancer stage allow meaningful assessments of changes in cancer incidence and outcomes, stage is not recorded by most population-based cancer registries. The main method of staging adult cancers is the TNM classification. The criteria for staging paediatric cancers, however, vary by diagnosis, have evolved over time, and sometimes vary by cooperative trial group. Consistency in the collection of staging data has therefore been challenging for population-based cancer registries. We assembled key experts and stakeholders (oncologists, cancer registrars, epidemiologists) and used a modified Delphi approach to establish principles for paediatric cancer stage collection. In this Review, we make recommendations on which staging systems should be adopted by population-based cancer registries for the major childhood cancers, including adaptations for low-income countries. Wide adoption of these guidelines in registries will ease international comparative incidence and outcome studies.",
author = "Sumit Gupta and Aitken, {Joanne F.} and Ute Bartels and James Brierley and Mae Dolendo and Paola Friedrich and Soad Fuentes-Alabi and Garrido, {Claudia P.} and Gemma Gatta and Mary Gospodarowicz and Thomas Gross and Howard, {Scott C.} and Elizabeth Molyneux and Florencia Moreno and Pole, {Jason D.} and Kathy Pritchard-Jones and Oscar Ramirez and Ries, {Lynn A.G.} and Carlos Rodriguez-Galindo and Shin, {Hee Young} and Eva Steliarova-Foucher and Lillian Sung and Eddy Supriyadi and Rajaraman Swaminathan and Julie Torode and Tushar Vora and Tezer Kutluk and Frazier, {A. Lindsay}",
year = "2016",
month = "4",
day = "1",
doi = "10.1016/S1470-2045(15)00539-2",
language = "English (US)",
volume = "17",
pages = "e163--e172",
journal = "The Lancet Oncology",
issn = "1470-2045",
publisher = "Lancet Publishing Group",
number = "4",

}

TY - JOUR

T1 - Paediatric cancer stage in population-based cancer registries

T2 - the Toronto consensus principles and guidelines

AU - Gupta, Sumit

AU - Aitken, Joanne F.

AU - Bartels, Ute

AU - Brierley, James

AU - Dolendo, Mae

AU - Friedrich, Paola

AU - Fuentes-Alabi, Soad

AU - Garrido, Claudia P.

AU - Gatta, Gemma

AU - Gospodarowicz, Mary

AU - Gross, Thomas

AU - Howard, Scott C.

AU - Molyneux, Elizabeth

AU - Moreno, Florencia

AU - Pole, Jason D.

AU - Pritchard-Jones, Kathy

AU - Ramirez, Oscar

AU - Ries, Lynn A.G.

AU - Rodriguez-Galindo, Carlos

AU - Shin, Hee Young

AU - Steliarova-Foucher, Eva

AU - Sung, Lillian

AU - Supriyadi, Eddy

AU - Swaminathan, Rajaraman

AU - Torode, Julie

AU - Vora, Tushar

AU - Kutluk, Tezer

AU - Frazier, A. Lindsay

PY - 2016/4/1

Y1 - 2016/4/1

N2 - Population-based cancer registries generate estimates of incidence and survival that are essential for cancer surveillance, research, and control strategies. Although data on cancer stage allow meaningful assessments of changes in cancer incidence and outcomes, stage is not recorded by most population-based cancer registries. The main method of staging adult cancers is the TNM classification. The criteria for staging paediatric cancers, however, vary by diagnosis, have evolved over time, and sometimes vary by cooperative trial group. Consistency in the collection of staging data has therefore been challenging for population-based cancer registries. We assembled key experts and stakeholders (oncologists, cancer registrars, epidemiologists) and used a modified Delphi approach to establish principles for paediatric cancer stage collection. In this Review, we make recommendations on which staging systems should be adopted by population-based cancer registries for the major childhood cancers, including adaptations for low-income countries. Wide adoption of these guidelines in registries will ease international comparative incidence and outcome studies.

AB - Population-based cancer registries generate estimates of incidence and survival that are essential for cancer surveillance, research, and control strategies. Although data on cancer stage allow meaningful assessments of changes in cancer incidence and outcomes, stage is not recorded by most population-based cancer registries. The main method of staging adult cancers is the TNM classification. The criteria for staging paediatric cancers, however, vary by diagnosis, have evolved over time, and sometimes vary by cooperative trial group. Consistency in the collection of staging data has therefore been challenging for population-based cancer registries. We assembled key experts and stakeholders (oncologists, cancer registrars, epidemiologists) and used a modified Delphi approach to establish principles for paediatric cancer stage collection. In this Review, we make recommendations on which staging systems should be adopted by population-based cancer registries for the major childhood cancers, including adaptations for low-income countries. Wide adoption of these guidelines in registries will ease international comparative incidence and outcome studies.

UR - http://www.scopus.com/inward/record.url?scp=84977475863&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84977475863&partnerID=8YFLogxK

U2 - 10.1016/S1470-2045(15)00539-2

DO - 10.1016/S1470-2045(15)00539-2

M3 - Review article

C2 - 27300676

AN - SCOPUS:84977475863

VL - 17

SP - e163-e172

JO - The Lancet Oncology

JF - The Lancet Oncology

SN - 1470-2045

IS - 4

ER -